Taylor Morrison Clears Major Regulatory Hurdle for Berkshire Hathaway Acquisition
TMHC sits 33% above its 52-week low of $54.15.
Summary
Taylor Morrison announced that a key antitrust waiting period for its $8.5 billion acquisition by Berkshire Hathaway has expired, moving the deal closer to completion.
Key Events · M&A and Partnerships · TMHC
-
HSR Waiting Period Expired
The Hart-Scott-Rodino Antitrust Improvements Act waiting period for the proposed acquisition by Berkshire Hathaway expired on July 6, 2026.
-
Merger Progresses
This satisfies a significant regulatory condition for the $8.5 billion all-cash merger, which was initially announced on May 31, 2026.
-
Remaining Conditions
The closing of the merger is still subject to other required regulatory approvals, adoption by shareholders, and customary closing conditions.
Analysis · TMHC · Real Estate & Construction
This filing confirms the expiration of the Hart-Scott-Rodino antitrust waiting period, a critical regulatory approval for the pending $8.5 billion acquisition of Taylor Morrison by Berkshire Hathaway. Clearing this hurdle significantly de-risks the transaction and moves it closer to completion. The stock is currently trading near the acquisition price of $72.50, reflecting high confidence in the deal closing.
At the time of this filing, TMHC was trading at $71.88 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $54.15 to $72.50. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.